A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)

Non-small cell lung cancer (NSCLC) patients, accounting for approximately 85% of lung cancer cases, are usually diagnosed in advanced stages. Traditional surgical resection and radiotherapy have very limited clinical benefits. The objective of this study was to develop and evaluate a targeted therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiashuai, Zhou, Zhuoxin (Zora), Chen, Kai, Kim, Seulhee, Cho, Irene Soohyun, Varadkar, Tanvi, Baker, Hailey, Cho, Ju Hwan, Zhou, Lufang, Liu, Xiaoguang (Margaret)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572050/
https://www.ncbi.nlm.nih.gov/pubmed/37830607
http://dx.doi.org/10.3390/cells12192393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572050/
https://www.ncbi.nlm.nih.gov/pubmed/37830607
http://dx.doi.org/10.3390/cells12192393

Ejemplares similares